137 related articles for article (PubMed ID: 21127929)
1. Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system.
Attisani M; Centofanti P; La Torre M; Campanella A; Sansone F; Rinaldi M
J Artif Organs; 2010 Dec; 13(4):202-6. PubMed ID: 21127929
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal anticoagulation in patients with a left ventricular assist device?
Rossi M; Serraino GF; Jiritano F; Renzulli A
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
4. Fixed-dose aspirin monotherapy compared with thromboelastography directed antiplatelet therapy in long-term management of left ventricular assist devices.
Fanelli SJ; Elzeneini M; Meece LE; Mahmoud A; Jeng EI; Harris N; Ahmed MM
J Card Surg; 2022 Sep; 37(9):2621-2628. PubMed ID: 35610463
[TBL] [Abstract][Full Text] [Related]
5. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
9. Analysis of platelet function during left ventricular support with the Incor and Excor system.
Etz C; Welp H; Rothenburger M; Tjan TD; Wenzelburger F; Schmidt C; Scheld HH; Schmid C
Heart Surg Forum; 2004; 7(5):E423-7. PubMed ID: 15799917
[TBL] [Abstract][Full Text] [Related]
10. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.
Meuris B; Arnout J; Vlasselaers D; Schetz M; Meyns B
Artif Organs; 2007 May; 31(5):402-5. PubMed ID: 17470211
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
14. Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices.
Fahnhorst SE; Beasley G; Goldberg JF; Martinez HR; Ryan KA; Towbin JA; Boston U; Absi M
Artif Organs; 2021 Jan; 45(1):38-45. PubMed ID: 33180355
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarct-related ventricular tachycardia.
Siontis KC; Jamé S; Sharaf Dabbagh G; Latchamsetty R; Jongnarangsin K; Morady F; Bogun FM
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):584-590. PubMed ID: 29315941
[TBL] [Abstract][Full Text] [Related]
17. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
18. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
20. Complications Arising From Perioperative Anticoagulant/Antiplatelet Therapy in Major Colorectal and Abdominal Wall Surgery.
Cui RBJ; Ng KS; Young CJ
Dis Colon Rectum; 2018 Nov; 61(11):1306-1315. PubMed ID: 30239396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
